| PERIOD ENDING | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | 31-Oct-08 | | Total Revenue | 434 | 263 | 565 | 581 | | Cost of Revenue | 306 | 280 | 420 | 539 | | | Gross Profit | 128 | (17) | 145 | 42 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,624 | 1,353 | 1,660 | 1,089 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,496) | (1,370) | (1,515) | (1,048) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| (90) | 409 |
-
| | Earnings Before Interest And Taxes | (1,496) | (1,458) | (1,106) | (1,048) | | Interest Expense | 438 | 28 | (35) | 134 | | Income Before Tax | (1,933) | (1,486) | (1,071) | (1,181) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest | 57 | 2 |
-
|
-
| | | | Net Income From Continuing Ops | (1,876) | (1,486) | (1,071) | (1,181) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,876) | (1,486) | (1,071) | (1,181) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,876) | ($1,486) | ($1,071) | ($1,181) |
|
0.01% Nasdaq 
0.50%
Income Statement
